STATIN DRUGS: ARE THEY WORTH IT?March 25, 2018
Good day all! I just returned from my Age Management Medical Group conference at the Bellagio in Las Vegas and had a great time! I missed all of you while I was there, soaking up soaking up the wisdom and data of a number of national thought leaders in different domains.
I was excited to hear that many of my colleagues are generating gratifying results that are similar to my own. They, too, have been incorporating advanced multifaceted approaches using data, based on supported integrative medical approaches.
This has inspired me to start a blog to celebrate and announce some of the advances that we are seeing in the personalization of the approaches to our patients. This will likewise create a forum so that I may share some of this exciting and robust data and share how we are implementing these new technologies at Infinite Health Integrative Medicine Center.
A number of new diagnostic modalities and treatment changes will be initiated at Infinite Health in the immediate future. I want to share, however, some thoughts I have regarding coronary artery and peripheral vascular disease that I found particularly, well, let’s just say annoying.
As many of you know, I’m not the biggest fan of prescription drug use, particularly when I know that I may avoid their pitfalls and expense by using our 4 Pillar Approach™. This, as many of you know, is based on the utilization of methods and treatments that are shown, to not only improve the way you feel (improved energy focus, drive mood, etc.), but these personalized programs use modalities documented by clinical trials to improve telomere length and stability, as well as induce genetic changes that favor longevity, prevent cancer and the other chronic diseases that are the bane and burden of our country’s health care system.
It is in optimizing the functions of your body and organs that we achieve these amazing results, and we are adding several new lines of approaches to our services, based on the information I gleaned from this conference.
So, what about those cholesterol-lowering drugs (statins)? These medications generate a fantastic $20 million to $25 billion a year for the pharmaceutical companies (Lipitor is the big winner here at $11 billion a year), granted, cardiovascular disease affects 12 million people in the United States and accounts for about one million deaths yearly.